Skip to content
Aperlena
Language:

Germany - Medicinal products - Open House biosimilar discount agreements 2026 - 26 - Tralokinumab

Original Deutschland - Arzneimittel - Open House Biologika Rabattverträge 2026 - 26 - Tralokinumab

Open Contract notice 675 days left
Watch this tender

Deadline 31 Jul. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 17 Jul, questions by 17 Jul, draft by 24 Jul. Log in

  1. Published
  2. Today
  3. Deadline open for 774 days
  4. Awarded pending

Summary

Machine-generated summary

Techniker Krankenkasse (TK), a German statutory health insurer, aims to conclude rebate agreements under § 130c paragraph 1 SGB V with all suitable pharmaceutical undertakers for the active substance Tralokinumab. The procedure is an Open House process: individual negotiations on contract contents do not take place and uniform conditions apply to all participants. TK guarantees no exclusivity to any contracting partner. The contract runs for a maximum of 24 months starting on 01.08.2026 and ends at the latest on 31.07.2028, regardless of the date of signature. If patent or market exclusivity expires earlier, the contract automatically ends at the end of that month. Further details are in the participation and contract documents.

Description

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Tralokinumab zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.08.2026. Der Vertrag endet spätestens am 31.07.2028, unabhängig vom Datum des Vertragsschlusses. Bei Patentablauf/Ablauf der Marktexklusivität vor dem o.g. Enddatum endet der Vertrag automatisch mit Ablauf des Monats des Patentablaufs/der Marktexklusivität. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

3 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,224,680
9,666 open across Europe right now
Buyer track record on Aperlena
4 notices tracked · 0 awarded

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

675 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close